Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Payables (2016 - 2026)

Orthopediatrics has reported Payables over the past 11 years, most recently at $19.9 million for Q1 2026.

  • For Q1 2026, Payables rose 39.96% year-over-year to $19.9 million; the TTM value through Mar 2026 reached $19.9 million, up 39.96%, while the annual FY2025 figure was $19.0 million, 83.36% up from the prior year.
  • Payables for Q1 2026 was $19.9 million at Orthopediatrics, up from $19.0 million in the prior quarter.
  • Over five years, Payables peaked at $22.6 million in Q3 2023 and troughed at $8.5 million in Q3 2025.
  • A 5-year average of $15.1 million and a median of $14.6 million in 2022 define the central range for Payables.
  • Biggest five-year swings in Payables: surged 107.58% in 2023 and later crashed 48.43% in 2024.
  • Year by year, Payables stood at $11.2 million in 2022, then increased by 13.44% to $12.6 million in 2023, then fell by 18.27% to $10.3 million in 2024, then skyrocketed by 83.36% to $19.0 million in 2025, then rose by 4.84% to $19.9 million in 2026.
  • Business Quant data shows Payables for KIDS at $19.9 million in Q1 2026, $19.0 million in Q4 2025, and $8.5 million in Q3 2025.